Search results for "610"

showing 10 items of 1353 documents

Temperature effects explain continental scale distribution of cyanobacterial toxins

2018

Insight into how environmental change determines the production and distribution of cyanobacterial toxins is necessary for risk assessment. Management guidelines currently focus on hepatotoxins (microcystins). Increasing attention is given to other classes, such as neurotoxins (e.g., anatoxin-a) and cytotoxins (e.g., cylindrospermopsin) due to their potency. Most studies examine the relationship between individual toxin variants and environmental factors, such as nutrients, temperature and light. In summer 2015, we collected samples across Europe to investigate the effect of nutrient and temperature gradients on the variability of toxin production at a continental scale. Direct and indirect…

light climate0106 biological sciencesthermoclineBacterial toxinstoksiinitlimit of quantitationToxines bacterianesMicrocystin-LRToxicology01 natural sciencesAnatoxin-aanalogs and derivativesBLOOMSDirect EffectsuracilWater Pollutantschemistry.chemical_classificationTemperaturesFRESH-WATERlatitudemaximum buoyancy frequency6. Clean waterclimate changeIndirect effectsEUTROPHICATIONmicrocystin RRarticlesGROWTHlämpötilaLAKESmicrocystin; anatoxin; cylindrospermopsin; temperature; direct effects; indirect effects; spatial distribution; European Multi Lake Surveyepilimnetic temperatureta1172cyanobacteria lakes climate warming microcystin; anatoxin; cylindrospermopsin; temperature; direct effects; indirect effects; spatial distribution; European Multi Lake SurveyZoologyArticlewater pollutantMICROCYSTIS-AERUGINOSAAlkaloidsSettore BIO/07 - ECOLOGIANATURAL SCIENCES. Biology.Spatial distributionMicrocystis aeruginosaUracillakesyanobakteeritIndirect Effectsliquid chromatography-mass spectrometry1172 Environmental sciencesEkologinutrient010604 marine biology & hydrobiologylcsh:RmicrobiologyClimatic changesmicrocystin LRAnatoxinLakesSpatial Distributionchemistrynodularinmicrobial diversityphytoplanktonta1181CylindrospermopsinTropanesCyanobacteriaAquatic Ecology and Water Quality ManagementanalysisHealth Toxicology and Mutagenesislcsh:Medicineenvironmental parameters010501 environmental sciencesmedicine.disease_causenitrogenchemistry.chemical_compoundsea surface temperatureenvironmental factorddc:550Canvi climàticphosphorusPRIRODNE ZNANOSTI. Biologija.limit of detectionEcologyCyanobacteria ToxinsbiologyTemperaturelevinneisyysmicrocystin ; anatoxin ; cylindrospermopsin ; temperature ; direct effects ; indirect effects ; spatial distribution ; European Multi Lake SurveyNodularintropane derivativeEuropeDAPHNIA-MAGNAİndirect EffectsCylindrospermopsinDirect effectsmicrobial communityEnvironmental Monitoringhigh performance liquid chromatographyMicrocystinsClimate ChangeBacterial ToxinsMicrocystinMicrocystinCyanobacteriavälittömät oikeusvaikutuksetcyanobacteriumddc:570geographic distributionmedicinebacterial toxincontrolled studyddc:610Institut für Biochemie und Biologie0105 earth and related environmental sciencesnonhumanWIMEKToxinlongitudePHYTOPLANKTON ASSEMBLAGESEuropean Multi Lake SurveyAquatic EcologyNITROGEN AVAILABILITYanatoxin aAquatische Ecologie en Waterkwaliteitsbeheerbiology.organism_classificationClimatic changeCLIMATE13. Climate actionresponse variableCanvis climàtics
researchProduct

Limitacions educatives del teatre escolar tradicional : reflexions i propostes escèniques alternatives

2014

En primer lloc, aquesta investigació s’endinsa en una reflexió sobre el teatre escolar tradicional per mostrar les diferents limitacions de caràcter educatiu que presenten aquestes pràctiques a l’escola. Posteriorment, la recerca planteja diferents propostes i estratègies metodològiques amb l’objectiu de resoldre aquestes limitacions. La investigació està fonamentada en l’ampla experiència personal del seu autor envers el teatre escolar i el gran nombre i varietat de muntatges teatrals realitzats, que serveixen de proves documentals per reforçar les hipòtesis que plantegem a la investigació.

limitacions6104.02 (Mètodes Educatius)teatreinnovacióeducació5801.07 (Mètodes Pedagògics)performance
researchProduct

Differential influence of vemurafenib and dabrafenib on patient lymphocytes despite similar clinical efficacy in melanoma

2014

Background: Since the majority of melanomas eventually become resistant and progress, combining selective BRAF inhibitors (BRAFi) with immunotherapies has been proposed to achieve more durable treatment responses. Here, we explored the impact of selective BRAFi on the hosts’ immune system. Patients and methods: Clinical data, whole blood counts (WBC) and serum lactate dehydrogenase (LDH) of 277 vemurafenib- and 65 dabrafenib-treated melanoma patients were evaluated. The frequency and phenotype of lymphocyte subpopulations were determined by flow cytometry while T cell cytokine secretion was measured by multiplex assays. Results: Progression-free survival (PFS) as well as overall survival (O…

lymphocytesmedicine.medical_treatmentT cellLymphocyte2720 HematologyMedizinT cells610 Medicine & healthPharmacology142-005 142-005melanomamedicineInterleukin 9dabrafenibVemurafenibtreatmentbusiness.industryMelanomaDabrafenibOriginal ArticlesHematologyImmunotherapymedicine.diseasemedicine.anatomical_structureOncology2730 OncologyvemurafenibCytokine secretionbusinessmedicine.drug
researchProduct

Mutant HRAS as novel target for MEK and mTOR inhibitors.

2015

HRAS is a frequently mutated oncogene in cancer. However, mutant HRAS as drug target has not been investigated so far. Here, we show that mutant HRAS hyperactivates the RAS and the mTOR pathway in various cancer cell lines including lung, bladder and esophageal cancer. HRAS mutation sensitized toward growth inhibition by the MEK inhibitors AZD6244, MEK162 and PD0325901. Further, we found that MEK inhibitors induce apoptosis in mutant HRAS cell lines but not in cell lines lacking RAS mutations. In addition, knockdown of HRAS by siRNA blocked cell growth in mutant HRAS cell lines. Inhibition of the PI3K pathway alone or in combination with MEK inhibitors did not alter signaling nor had an imp…

mTOR inhibitorMutantBlotting Western610 Medicine & healthApoptosisMice SCIDCell LineProto-Oncogene Proteins p21(ras)chemistry.chemical_compoundCell Line TumorNeoplasmsMedicineAnimalsHumansHRASHRAS mutationsProtein Kinase InhibitorsPI3K/AKT/mTOR pathwayCell ProliferationGeneticsMitogen-Activated Protein Kinase KinasesMEK inhibitorOncogeneCell growthbusiness.industryMEK inhibitorTOR Serine-Threonine KinasesDiphenylamineXenograft Model Antitumor AssaysTumor Burdenlung cancer10219 Clinic for Gastroenterology and HepatologyCell Transformation NeoplasticOncologychemistry10032 Clinic for Oncology and HematologyBenzamidesMutationCancer researchbladder cancer2730 OncologyBenzimidazolesRNA InterferenceSignal transductionGrowth inhibitionbusinessSignal TransductionResearch PaperOncotarget
researchProduct

Automatic Processing of Changes in Facial Emotions in Dysphoria: A Magnetoencephalography Study

2018

It is not known to what extent the automatic encoding and change detection of peripherally presented facial emotion is altered in dysphoria. The negative bias in automatic face processing in particular has rarely been studied. We used magnetoencephalography (MEG) to record automatic brain responses to happy and sad faces in dysphoric (Beck’s Depression Inventory ≥ 13) and control participants. Stimuli were presented in a passive oddball condition, which allowed potential negative bias in dysphoria at different stages of face processing (M100, M170, and M300) and alterations of change detection (visual mismatch negativity, vMMN) to be investigated. The magnetic counterpart of the vMMN was el…

magnetoencephalographyMismatch negativityAutomatic processinghavaitseminenfacial expressionsAudiology170 Ethics2738 Psychiatry and Mental HealthBehavioral Neuroscience0302 clinical medicine2802 Behavioral Neurosciencechange detectionta515dysphoriaOriginal ResearchMEGmedicine.diagnostic_test05 social sciencesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyNeurologymedicine.symptomPsychology2803 Biological PsychiatryChange detectionmasennusmedicine.medical_specialtydepression (mental disorders)610 Medicine & healthOccipital regionemotionsDysphoriata3112behavioral disciplines and activities050105 experimental psychologylcsh:RC321-5713206 Neuropsychology and Physiological Psychology03 medical and health sciencesperception (activity)Group differencestunteetmedicineemotional faces10237 Institute of Biomedical Engineering0501 psychology and cognitive sciencesilmeetlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryMagnetoencephalographyNegative bias2808 Neurologyautomatic030217 neurology & neurosurgeryNeuroscienceFrontiers in Human Neuroscience
researchProduct

Unilateral Maximal Isometric Hex Bar Pull Test : Within-Session Reliability and Lower Body Force Production in Male and Female Freeski Athletes

2021

The aim of the study was to (1) assess the within-session reliability of a unilateral isometric hex bar pull (UIHBP) maximal voluntary contraction (MVC) test and, (2) determine unilateral isometric absolute peak force (PFabs) and relative peak force (PF) values in freeski athletes. Twenty-one male and eight female academy to national team freeskiers performed the novel UIHBP MVC task on a force plate and PFabs and relative PF were assessed (1000 Hz). Within-session measures of PFabs offered high reliability on left and right limbs for males (ICC = 0.91–0.94, CV = 2.6–2.2%) and females (ICC = 0.94–0.94, CV = 1.4–1.6%), while relative PF measures showed good to high reliability in both left a…

maximalcontraction610 Medicine & healthisometricfreestylefreeskiingstrength testingskiingalppilajitunilateral10046 Balgrist University Hospital Swiss Spinal Cord Injury Centervoimantuotto (fysiologia)voluntarybiomekaniikka
researchProduct

SETAC GLB and SETAC Europe SAC: a liaison promoting the next generation of ecotoxicologists and environmental chemists

2018

Environmental sciences Europe 30(1), 41s12302-018-0171-z (2018). doi:10.1186/s12302-018-0171-z

media_common.quotation_subject0208 environmental biotechnologyenvironmental chemistsFace (sociological concept)61002 engineering and technology010501 environmental sciencesecotoxicologists01 natural sciencesGermanddc:570Gratitudeddc:610lcsh:Environmental sciences0105 earth and related environmental sciencesmedia_commonlcsh:GE1-350lcsh:Environmental lawympäristökemiaPollutionlanguage.human_language020801 environmental engineeringekotoksikologialcsh:K3581-3598EditoriallanguageEngineering ethics
researchProduct

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition.

2021

Abstract Direct oral anti–activated factor X and antithrombin agents have largely replaced vitamin K antagonists as the standard of care in treatment of venous thromboembolism. However, gaps in efficacy and safety persist, notably in end‐stage renal disease, implantable heart valves or assist devices, extracorporeal support of the circulation, and antiphospholipid syndrome. Inhibition of coagulation factor XI (FXI) emerges as a promising new therapeutic target. Antisense oligonucleotides offer potential advantages as a prophylactic or therapeutic modality, with one dose‐finding trial in orthopedic surgery already published. In addition, monoclonal antibodies blocking activation and/or activ…

medicine.drug_class2720 Hematologyvenous thromboembolism610 Medicine & healthBioinformaticslaw.inventionchemistry.chemical_compoundRandomized controlled trialAntiphospholipid syndromelawAntithromboticMedicineDiseases of the blood and blood-forming organsFactor XIIbusiness.industrycatheter(s)Factor X10031 Clinic for AngiologyAntithrombinAnticoagulantanticoagulantHematologycontact systemmedicine.diseasefactor XIPulmonary embolismchemistryRC633-647.5businessState of the Art Isth 2020medicine.drugResearch and practice in thrombosis and haemostasis
researchProduct

Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells

2021

Crizotinib was a first generation of ALK tyrosine kinase inhibitor approved for the treatment of ALK-positive non-small-cell lung carcinoma (NSCLC) patients. COMPARE and cluster analyses of transcriptomic data of the NCI cell line panel indicated that genes with different cellular functions regulated the sensitivity or resistance of cancer cells to crizotinib. Transcription factor binding motif analyses in gene promoters divulged two transcription factors possibly regulating the expression of these genes, i.e., RXRA and GATA1, which are important for leukemia and erythroid development, respectively. COMPARE analyses also implied that cell lines of various cancer types displayed varying degr…

medicine.drug_classPharmaceutical Scienceacute myeloid leukemiaArticletranscriptomicsPharmacy and materia medicaDrug Discoverytyrosine kinase inhibitorsmedicineCytotoxic T cellnetwork pharmacologyddc:610biologyCrizotinibdrug repurposingChemistryTopoisomeraseRMyeloid leukemiaCell cyclemedicine.diseaseALK inhibitorRS1-441multiple myelomaLeukemiaCancer cellbiology.proteinCancer researchMolecular MedicineMedicinemedicine.drug
researchProduct

Online prevention programmes for university students: stakeholder perspectives from six European countries

2021

Abstract Background Students beginning university are at a heightened risk for developing mental health disorders. Online prevention and early intervention programmes targeting mental health have the potential to reduce this risk, however, previous research has shown uptake to be rather poor. Understanding university stakeholders’ (e.g. governing level and delivery staff [DS] and students) views and attitudes towards such online prevention programmes could help with their development, implementation and dissemination within university settings. Methods Semi-structured interviews, focus groups and online surveys were completed with staff at a governing level, university students and DS (i.e.…

medicine.medical_specialty020205 medical informaticsUniversitiesTeaching staff610 Medicine & health02 engineering and technology03 medical and health sciences0302 clinical medicineSDG 17 - Partnerships for the GoalspreventionIntervention (counseling)0202 electrical engineering electronic engineering information engineeringmedicineHumansAcademicSubjects/MED00860AcademicSubjects/SOC01210030212 general & internal medicine610 Medicine & healthStudentsMedical educationbusiness.industryPart II: ICare Stakeholder SurveyPublic healthMental DisordersPublic Health Environmental and Occupational HealthStakeholdercollege students/dk/atira/pure/sustainabledevelopmentgoals/partnershipsUsabilityMental healthFocus groupprevention programmental disordersMental HealthAttitudeattitudeThematic analysisPsychologybusinessAcademicSubjects/SOC02610mental health
researchProduct